Subscribe
Menu
Login
Login
Subscribe
News & Opinion
Publications
AN INTERACTIVE EXPERIENCE
Current Issue
April 2024
View This Issue
Archives
Features
Quarterly Magazine
Current Issue
Spring 2024
View This Issue
Archives
Features
Categories
Biochemistry
Cancer
Cell Biology
Community
Drug Development
Environment
Evolution
Genetics
Immunology
Microbiology
Neuroscience
Physiology
Public Health
Zoology
TS University
Scientific Services
Brush Up Summaries
Technique Talks
Journal Club
TS SciComm
Multimedia
Crossword Puzzles
eBooks
Infographics
Podcasts
Research Products Blog
Research Articles
Science Snapshot
Slideshows
Videos
Words for Nerds
Webinars
ADVERTISEMENT
Home
Subjects
clinical trials, science publishing
clinical trials, science publishing
New Automated Tool Monitors Clinical Trial Reporting
Diana Kwon
| Feb 21, 2018
| 3 min read
The watchdog website FDAAA TrialsTracker names and shames human studies that breach the FDA’s requirements for reporting results.
More Than 1 Percent of Clinical Trial Reports Appear Flawed
Jef Akst
| Jun 5, 2017
| 2 min read
A new screening tool flags dozens of papers with potential errors.
WHO: Share Trial Data
Tracy Vence
| Apr 15, 2015
| 1 min read
The World Health Organization again calls upon researchers to register clinical trial details in freely accessible databases before initiation of the study.
Week in Review: June 16–20
Tracy Vence
| Jun 20, 2014
| 2 min read
Early Neanderthal evolution; developing antivirals to combat polio; the mouth and skin microbiomes; insect-inspired, flight-stabilizing sensors
Week in Review, July 15–19
Jef Akst
| Jul 19, 2013
| 5 min read
Bias in preclinical research; medical marijuana for kids; a swath of microbial genomes; plastic ocean habitats; rethinking scientific evaluation
Scientists "Spin" Results
Bob Grant
| Sep 13, 2012
| 2 min read
A new study of the scientific literature finds that researchers are guilty of overemphasizing the benefits of medical treatments.
Overhauling Industry-Sponsored Studies
Bob Grant
| May 23, 2012
| 2 min read
Major pharmaceutical companies have agreed to a handful of recommendations aimed at increasing the transparency of clinical trials they fund.
ADVERTISEMENT